Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bupropion sustained release: a therapeutic overview

J R Davidson1, K M Connor

  • 1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.

The Journal of Clinical Psychiatry
|April 29, 1998
PubMed
Summary

Sustained-release bupropion (bupropion SR) is an effective antidepressant, demonstrating therapeutic benefits over placebo in clinical trials. Low doses of bupropion SR show efficacy, offering an alternative to serotonergic antidepressants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 and vertical transmission: assessing the expression of ACE2/TMPRSS2 in the human fetus and placenta to assess the risk of SARS-CoV-2 infection.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Missed opportunities for ovarian salvage in children: an 8-year review of surgically managed ovarian lesions at a tertiary pediatric surgery centre.

Pediatric surgery international·2021
Same author

Sexual function, quality of life, and fertility in women who had surgery for neonatal Hirschsprung's disease.

The British journal of surgery·2021
Same author

Improvise, Adapt, Overcome: mobile phone LED used as a light source for cystoscopy and resection of posterior urethral valves in a low-cost setting.

Journal of pediatric urology·2018
Same author

Macrophage- and RIP3-dependent inflammasome activation exacerbates retinal detachment-induced photoreceptor cell death.

Cell death & disease·2015
Same author

Mammalian STE20-like kinase 2, not kinase 1, mediates photoreceptor cell death during retinal detachment.

Cell death & disease·2014

Area of Science:

  • Pharmacology and Psychiatry
  • Neuroscience
  • Clinical Therapeutics

Background:

  • Bupropion, an established antidepressant, is now available in a sustained-release (SR) formulation.
  • Understanding bupropion SR's pharmacokinetics, mechanism, metabolism, and efficacy is crucial for its clinical application.

Purpose of the Study:

  • To review the properties and efficacy of sustained-release bupropion (bupropion SR).
  • To compare bupropion SR with placebo and serotonergic antidepressants.
  • To introduce the catecholamine-indolamine spectrum concept for differential therapeutics.

Main Methods:

  • Review of pharmacokinetic, mechanistic, metabolic, and efficacy data for bupropion SR.
  • Analysis of results from large, multicenter, placebo-controlled trials.

Related Experiment Videos

  • Comparative analysis of bupropion SR and serotonergic agents.

    • Main Results:

    • Bupropion SR demonstrated significant benefit over placebo in large multicenter trials.
    • Low doses (100-150 mg) of bupropion SR were found to be therapeutically effective.
    • Differential properties of bupropion SR compared to serotonergic drugs were described.

    Conclusions:

    • Sustained-release bupropion is an effective antidepressant option.
    • Bupropion SR offers a distinct therapeutic profile, potentially useful in differential treatment strategies.
    • The catecholamine-indolamine spectrum provides a framework for understanding selective antidepressant actions.